| JANUS HENDERSON GLOBAL LIFE SCIENCES I2 USD | RVI BIOTECNOLOGÍA | 47,58% | 43,68% | 52,21% | 177,07% |
| VONTOBEL FUND-MTX ASIAN LEADERS (EX JAPAN) AHI (HEDGED) EUR DIS | RVI ASIA EX-JAPÓN | 47,58% | 75,14% | 20,39% | · |
| CARMIGNAC PORTFOLIO EMERGENTS A EUR YDIS | RVI EMERGENTES | 47,57% | 66,43% | 26,51% | · |
| SCHRODER ISF CHINA A C ACC EUR (HEDGED) | RVI CHINA | 47,57% | 39,26% | -12,93% | · |
| BNP PARIBAS JAPAN SMALL CAP PRIVILEGE CAP | RVI JAPÓN SMALL/MID CAP | 47,56% | 91,28% | 79,53% | 182,99% |
| AVIVA INVESTORS - GLOBAL EMERGING MARKETS CORE B EUR | RVI EMERGENTES | 47,54% | 76,93% | 46,84% | 87,25% |
| BGF EMERGING MARKETS EQUITY INCOME A6 HKD (HEDGED) | RVI EMERGENTES | 47,51% | 56,75% | 23,84% | 74,41% |
| CT (LUX) ASIAN EQUITY INCOME DE EUR | RVI ASIA EX-JAPÓN | 47,47% | 65,36% | 40,06% | 147,51% |
| HSBC GIF ASIA EX JAPAN EQUITY IC USD | RVI ASIA EX-JAPÓN | 47,47% | 74,54% | 26,46% | 152,85% |
| FTGF ROYCE US SMALL CAP OPPORTUNITY X EUR CAP | RVI USA SMALL/MID CAP | 47,46% | 63,16% | 65,17% | · |
